Search

everythinglearnresearchcommunity

for

Search:↓

A patient with patchy hair loss was successfully treated for Tumid Lupus Erythematosus after other treatments failed.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Early treatment of traction alopecia can reverse hair loss; prevention involves avoiding tight hairstyles.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

The document concludes that it's important to recognize and treat hair loss in women of color, considering their unique hair characteristics and psychological impact.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

Oral cyclosporine is more effective and safer than betamethasone for treating alopecia areata.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

Alopecia areata patients have higher levels of IL-6 and TNF-α.

Microneedling with betamethasone led to almost complete hair regrowth in severe alopecia areata.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Using growth factors and microneedling shows promise for hair regrowth in Alopecia Areata, but more research is needed.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

Experts recommend personalized treatment plans for best outcomes in managing Alopecia Areata.

Platelet-rich plasma therapy is a safe and effective treatment for alopecia areata.

ADHD stimulant medications might be linked to a specific type of hair loss called Alopecia Universalis.

Trichoscopy helps diagnose frontal fibrosing alopecia, even with unusual patterns.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

A woman with an unusual pattern of hair loss was confirmed to have Frontal Fibrosing Alopecia and treated with specific medications.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

The document concludes that different types of hair loss have specific treatments, and early diagnosis is crucial for preventing permanent hair loss.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Frontal fibrosing alopecia may be linked to genital Lichen sclerosus through an autoimmune process.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

The patient with total hair loss did not regrow hair despite treatment, indicating a poor outlook for this type of hair loss.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.